{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-000383","form_type":"8-K","ticker":"MRMD","cik":"0001522767","company_name":"MARIMED INC.","filed_at":"2022-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.844332+00:00","generated_at":"2026-06-27T20:35:16.452696+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MariMed agrees to acquire Kind Therapeutics USA for $20M; buys minority interests for $2M","bullets":["Acquires 100% of Kind Therapeutics for $20M: $13.5M cash, $6.5M in 4-year 6% promissory notes.","Also buys minority interests in two subsidiaries for $2M, gaining ~99.7% of Mari-MD and ~94.3% of Mia.","Kind holds Maryland medical cannabis licenses for cultivation, production, and provisional dispensary.","Closing subject to Maryland Medical Cannabis Commission approval; related litigation dismissed with prejudice.","CEO Bob Fireman expects another transformational year; MariMed already manages Kind's operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-000383","json":"https://secwatch.observer/filing/0001493152-22-000383.json","markdown":"https://secwatch.observer/filing/0001493152-22-000383.md","text":"https://secwatch.observer/filing/0001493152-22-000383.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522767/000149315222000383/0001493152-22-000383-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522767/000149315222000383/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:35:16.452696+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}